Authors
Loading...
CCM feasible as adjunct in CRT non-responders; leaves open clinical benefit pending prospective trials.
Key points are not available for this paper at this time.
Nägele et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: